# An International Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Who Are All Receiving the Local Standard of Care - WHO-SOLIDARITY-GERMANY

> **NCT04575064** · PHASE2,PHASE3 · WITHDRAWN · sponsor: **Professor Dr. Bernd Mühlbauer**

## Conditions studied

- SARS-CoV-2 Infection
- COVID-19
- Moderate and Severe COVID-19

## Interventions

- **OTHER:** Standard of Care (SoC)
- **DRUG:** Remdesivir

## Key facts

- **NCT ID:** NCT04575064
- **Lead sponsor:** Professor Dr. Bernd Mühlbauer
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-06-29
- **Primary completion:** 2022-03
- **Final completion:** 2022-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Explanation will be submitted later.
- **Last updated:** 2024-10-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04575064

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04575064, "An International Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Who Are All Receiving the Local Standard of Care - WHO-SOLIDARITY-GERMANY". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04575064. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*